PhRMA
FEBRUARY 16, 2023
Did you know that insurance companies use middlemen — known as pharmacy benefit managers (PBMs) — to decide what medicines people can get and what people pay out of pocket for those medicines?
Drug Topics
FEBRUARY 16, 2023
Nearly 40 million people in the United States suffer from migraine, with the World Health Organization classifying migraine as 1 of the 10 most disabling medical illnesses.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
FEBRUARY 16, 2023
Matt Fitzgerald used to bike up and down 3,500 feet through the Santa Ana Mountains on three-hour rides just for fun. Now, nine months after being infected with SARS-CoV-2, the virus that causes Covid-19, he can’t muster walking on flat surfaces for 20 minutes without days of exhaustion. “My long Covid life remains terrifying,” he told me.
Drug Topics
FEBRUARY 16, 2023
The founder of Mark Cuban Cost Plus Drug Company called drug pricing "insane" during a fireside chat at the Association of Accessible Medicines annual meeting.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 16, 2023
Akin Akinc was scouring his email spam box last summer, looking for a missing message, when he stumbled across an unexpected email from a quite recognizable name: Feng Zhang. Zhang, one of the leading scientists in the groundbreaking field of genetic editing, had reached out two days prior to discuss a new company he was working on. Since helping to discover CRISPR-Cas9 — often referred to as molecular scissors that can cut into the genome and edit DNA — Zhang has founded at least
Drug Topics
FEBRUARY 16, 2023
Collections of oncology drugs in 13 states are being redistributed to patients in need.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Store News
FEBRUARY 16, 2023
The fudgy oat milk-based frozen dessert bars are available in four flavors — fudge n’ vanilla crunch, double chocolate fudge, fudge n’ caramel crunch and mint n’ fudge chip.
Drug Topics
FEBRUARY 16, 2023
Analysts have identifed treatments that may deliver annual sales topping $1 billion over the next 5 years.
Fierce Healthcare
FEBRUARY 16, 2023
Senate panel launches effort to shore up health workforce and ease crippling shortages rking Thu, 02/16/2023 - 16:52
STAT
FEBRUARY 16, 2023
With hundreds of genes thought to be linked to obesity, the challenge is sifting through them all to determine which ones increase the risk of downstream complications like heart disease and diabetes. In a study published Thursday in Nature Genetics, researchers took the first steps in finding a potential candidate specifically in women.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
FEBRUARY 16, 2023
Analysis: Medicare Advantage plans more likely to deny inpatient claims pminemyer Thu, 02/16/2023 - 14:16
STAT
FEBRUARY 16, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Hospital Pharmacy Europe
FEBRUARY 16, 2023
The results of a cluster, RCT by UK researchers showed that a care home intervention involving independent pharmacist prescribers was unable to reduce the fall rate among residents over a six month period in comparison to a usual care, but had a significant impact on drug burden index. Older residents in a care home (CH) are recognised as being at a potentially higher risk of medication error and adverse drug reactions due to both polypharmacy and age-related alterations in drug pharmacokinetics
STAT
FEBRUARY 16, 2023
Good morning, and happy Thursday from STAT reporter Andrew Joseph, here filling in for Ed for the day. We’re up and at ‘em on this weirdly warm February day, thanks to today’s cup of stimulation, which promises notes of blueberry and toffee (we’re a light roast, whole milk kind of household). Subtle flavors aside, we’re more focused on the dangerously low levels of beans left in the grinder.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The Checkup by Singlecare
FEBRUARY 16, 2023
If you’ve ever researched skin care products that can help reduce wrinkles and fine lines or improve acne, you might have stumbled upon a treatment called tretinoin. Tretinoin is a medication used on the skin that has been shown to aid in certain skin conditions and cosmetic goals. Keep reading to learn more about tretinoin, how it should be used, and safety precautions to keep in mind while using this medication.
STAT
FEBRUARY 16, 2023
Is the pharmaceutical lobby on the ropes? What does it mean when a vaccine is “free”? And does biotech prepare you for the presidency? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Vas Narasimhan, CEO of Novartis and the new chairman of PhRMA, joins us to discuss the industry’s struggles in Washington and whether the deflated biotech sector is still overvalued.
Fierce Healthcare
FEBRUARY 16, 2023
Adventist Health launches reorganization, lays off 52 administrative employees dmuoio Thu, 02/16/2023 - 16:26
Pharmaceutical Technology
FEBRUARY 16, 2023
The University of Texas MD Anderson Cancer Center has entered a strategic collaboration with biotech company Xilis for advancing new technology and expediting new cancer therapy development. The preclinical research deal will combine the MicroOrganoSphere (MOS) platform of Xilis with the expertise of MD Anderson for advancing new therapies development and cancer research.
The Checkup by Singlecare
FEBRUARY 16, 2023
Aspirin | Ibuprofen | Naproxen | Diclofenac | Best OTC anti-inflammatories | Side effects | Prescription vs. OTC anti-inflammatories If you experience minor aches and pains, an anti-inflammatory medicine may be the first thing you look for at the pharmacy. There are many different over-the-counter (OTC) drugs that can help relieve inflammation and pain, and they typically fall under the same class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs).
Drug Store News
FEBRUARY 16, 2023
The Secret Nature of Fruit supplements uncovers and harnesses the hidden secrets of fruits to deliver key functional nutrients, the company said.
The Checkup by Singlecare
FEBRUARY 16, 2023
The probiotics industry contributes billions of dollars to the U.S. economy each year. With that being said, patients may look to purchase probiotics on their own accord or under the direction of their healthcare provider. Although they’re not usually regulated by the FDA and the guidelines for their use are relatively scarce, probiotics have been shown to have several health benefits.
Outsourcing Pharma
FEBRUARY 16, 2023
Scientists can now dramatically reduce trial-and-error experimentation and uncover risks early thanks to an artificial intelligence solutions company.
Drug Store News
FEBRUARY 16, 2023
Retail sales in January were up 1.5% from December and increased 4.8% year-over-year, according to the National Retail Federation.
Fierce Healthcare
FEBRUARY 16, 2023
Many patients leave the doctor's office with unanswered questions: survey fdiamond Thu, 02/16/2023 - 08:34
Drug Store News
FEBRUARY 16, 2023
DSN spoke to Alexis Ansley-Benjamin, director of communications at DevaCurl, about the Mist of Wonders Leave-In Multi-Benefit Curl Spray.
Fierce Pharma
FEBRUARY 16, 2023
Ahead of next month's FDA decision, Emergent aces AdComm for over-the-counter Narcan nod fkansteiner Thu, 02/16/2023 - 14:12
Drug Store News
FEBRUARY 16, 2023
RangeMe's Retail Recap 2022 report finds that coffee, candy and mushrooms were top-of-mind among retail buyers within the last year.
Drug Topics
FEBRUARY 16, 2023
A smartphone app is associated with improvement in HbA1c levels, but physician involvement with patients and other factors may be the benefit.
Fierce Pharma
FEBRUARY 16, 2023
Moderna CEO accepts invite to talk vaccine pricing in Congress—just as his company makes access pledge fkansteiner Thu, 02/16/2023 - 11:22
The FDA Law Blog
FEBRUARY 16, 2023
By Kalie E. Richardson — On February 15, 2023, the Nonprescription Drugs Advisory Committee (NDAC) and the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) held a joint meeting to discuss an application pending before FDA that would switch Narcan (naloxone) Nasal Spray from prescription to over-the-counter (OTC) status. All 19 members of the joint Advisory Committee agreed that the benefit-risk profile of Narcan Nasal Spray (NNS) is “supportive of its use as a nonprescription
Pharmaceutical Technology
FEBRUARY 16, 2023
Aqilion and Merck have entered an exclusive licence and strategic research partnership for the discovery, development and commercialisation of the transforming growth factor-β-activated kinase 1 (TAK1) protein-small molecule inhibitors. Under the deal, Aqilion will receive $10.6m (€10m) in upfront cash payment from Merck and also eligible for up to $1,015m (€950m) in potential development and commercialisation milestone payments, along with tiered royalties on global net sales.
PharmExec
FEBRUARY 16, 2023
Fran Pollaro talks with Faruk Capan is the CEO, EVERSANA INTOUCH & Chief Innovation Officer, EVERSANA about the arrival of Chat GPT and generative AI in the public consciousness. This is just the beginning.
Pharmaceutical Technology
FEBRUARY 16, 2023
Ophthalmic technology firm Eyenovia and Formosa Pharmaceuticals have entered a collaboration agreement to develop new ophthalmic therapeutics. The collaboration will combine the Optejet dispensing technology of Eyenovia with the APNT nanoparticle formulation platform of Formosa to develop topical therapeutics. The Optejet microdose formulation and delivery platform use Microdose Array Print (MAP) technology for delivering 6ml-8ml of the drug.
Fierce Healthcare
FEBRUARY 16, 2023
Elation adds medical biller Lightning MD with plans to be the sector's first all-in-one technology solution aburky Thu, 02/16/2023 - 12:52
Expert insights. Personalized for you.
298 
Let's personalize your content